Loading organizations...
Loading organizations...
Developing novel therapies for neurodegenerative diseases.
AZTherapies has raised $59.9M across 2 funding rounds.
AZTherapies has raised $59.9M in total across 2 funding rounds.
AZTherapies has raised $59.9M in total across 2 funding rounds.
AZTherapies's investors include Duopharma Biotech Berhad, Cosine, Tas Parafestas, Drads Capital, IBS Capital, Wexford Capital.
AZTherapies has raised $59.9M across 2 funding rounds. Most recently, it raised $33.6M Series C in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 2, 2020 | $33.6M Series C | Duopharma Biotech Berhad | |
| Oct 17, 2019 | $26.3M Series C | Cosine, Tas Parafestas | Drads Capital, IBS Capital, Wexford Capital |